Effect of triiodothyronine (T₃) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats

References

• MurrayCJLLopezADThe Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Disease, Injuries, and Risk Factors in 1990 and Projected to 2020Cambridge, MAHarvard University Press19961
   Google Scholar
• FavaMDiagnosis and definition of treatment-resistant depressionBiol Psychiatry20035364965912706951
   PubMed Web of Science ®Google Scholar
• JoffeRTLevittAJSokolovSTAugmentation strategiesJ Clin Psychiatry19965725318690693
   PubMed Web of Science ®Google Scholar
• ConnollyKRThaseMEIf at first you don’t succeed: a review of the evidence for antidepressant augmentation, combination and switching strategiesDrugs201171436421175239
   PubMed Web of Science ®Google Scholar
• Cooper-KazazRLererBEfficacy and safety of triiodothyronine supplement in patients with major depressive disorder treated with specific serotonin reuptake inhibitorsInt J Neuropsychopharmacol20081168569918047754
   PubMed Web of Science ®Google Scholar
• AbrahamGMilevRStuartJLT3 augmentation of SSRI resistant depressionJ Affect Disord20069121121516483669
   PubMed Web of Science ®Google Scholar
• AltshulerLLBauerMFryeMADoes thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literatureAm J Psychiatry20011581617162211578993
   PubMed Web of Science ®Google Scholar
• NierenbergAAFavaMTrivediMHA comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D reportAm J Psychiatry20061631519153016946176
   PubMed Web of Science ®Google Scholar
• RushAJTrivediMHWisniewskiSRAcute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D reportAm J Psychiatry20061631905191717074942
   PubMed Web of Science ®Google Scholar
• PapakostasGICooper-KazazRAppelhofBCSimultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studiesInt Clin Psychopharmacol200924192519092448
   PubMed Web of Science ®Google Scholar
• GurELererBNewmanMEChronic clomipramine and triiodothyronine increases serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activityJ Pharmacol Exp Ther199928881879862756
   PubMed Web of Science ®Google Scholar
• GurELifschytzTLererBNewmanMEEffects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortexEur J Pharmacol2002457374312460641
   PubMed Web of Science ®Google Scholar
• MoreauXJeanningrosRMazzola-PomiettoPChronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brainNeuropsychopharmacology20012465266211331145
   PubMed Web of Science ®Google Scholar
• BauerMHeinzAWhybrowPCThyroid hormones, serotonin and mood: of synergy and significance in the adult brainMol Psychiatry2002714015611840307
   PubMed Web of Science ®Google Scholar
• RichelsonEInteractions of antidepressants with neurotransmitter transporters and receptors and their clinical relevanceJ Clin Psychiatry200364Suppl 1351214552650
   PubMed Web of Science ®Google Scholar
• MoretCCharveronMFinbergJPCouzinierJPBrileyMBiochemical profile of midalcipran (F 2207), 1-phenyl-1-diethyl-aminocarbonyl-2-aminomethyl-cyclopropane (Z) hydrochloride, a potential fourth generation antidepressant drugNeuropharmacology198524121121193005901
   PubMed Web of Science ®Google Scholar
• MochizukiDTsujitaRYamadaSNeurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in ratsPsychopharmacology (Berl)200216232333212122491
   PubMed Web of Science ®Google Scholar
• VaishnaviSNNemeroffCBPlottSJRaoSGKranzlerJOwensMJMilnacipran: a comparative analysis of human monoamine uptake and transporter binding affinityBiol Psychiatry20045532032214744476
   PubMed Web of Science ®Google Scholar
• QuidéYWitterveenABEl-HageWVeltmanDJOlffMDifferences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: a systematic reviewNeurosci Biobehav Rev20123662664421963442
   PubMed Web of Science ®Google Scholar
• KitaichiYInoueTNakagawaSIzumiTKoyamaTEffect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithiumEur J Pharmacol200551621922615963494
   PubMed Web of Science ®Google Scholar
• PaxinosGWatsonCThe Rat Brain in Stereotaxic Coordinates3rd edSan Diego, CAAcademic Press1997
   Google Scholar
• KitaichiYInoueTIzumiTEffect of co-administration of a serotonin-noradrenaline reuptake inhibitor and a dopamine agonist on extracellular monoamine concentrations in ratsEur J Pharmacol200858428529018336812
   PubMed Web of Science ®Google Scholar
• LifschytzTGoltser-DubnerTLandshutGLererBEffect of triiodothyronine on 5-HT1A and 5-HT1B receptor expression in rat forebrain and on latency to feed in the novelty suppressed feeding testProg Neuropsychopharmacol Biol Psychiatry20103463263820206658
   PubMed Web of Science ®Google Scholar
• EitanRLandshutGLifschytzTEinsteinOBen-HurTLererBThe thyroid hormone, triiodothyronine, enhances fluoxetine-induced neurogenesis in rats: possible role in antidepressant-augmenting propertiesInt J Neuropsychopharmacol20101355356119835665
   PubMed Web of Science ®Google Scholar
• KitaichiYInoueTIzumiTNakagawaSKatoAKoyamaTSubchronic milnacipran treatment increases basal extracellular noradrenaline concentrations in the medial prefrontal cortex of ratsEur J Pharmacol2005520374216153636
   PubMed Web of Science ®Google Scholar